Related Experiment Video
Updated: Dec 16, 2025

10:24
Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons
Published on: August 29, 2014
84.3K
Leveraging nature's biomolecular designs in next-generation protein sequencing reagent development
Jennifer Tullman1, John P Marino1, Zvi Kelman2,3
1Institute for Bioscience and Biotechnology Research (IBBR), National Institute of Standards and Technology (NIST) and the University of Maryland (UMD), 9600 Gudelsky Drive, Rockville, MD, 20850, USA.
Applied Microbiology and Biotechnology
|July 4, 2020
Summary
Next-generation protein sequencing uses fluorescently labeled binders to read N-terminal amino acids. Developing high-affinity N-terminal amino acid binders (NAABs) from natural biomolecules is key for this proteomics revolution.
Area of Science:
- Biochemistry
- Proteomics
- Molecular Biology
Background:
- Emerging next-generation sequencing technologies promise to revolutionize proteomics.
- Fluorescence-based imaging of immobilized peptides offers a novel sequencing approach.
- This method relies on sequential readout of N-terminal amino acids via fluorescently labeled biomolecules.
Purpose of the Study:
- To address the challenge of developing high-affinity and selective N-terminal amino acid binder (NAAB) reagents.
- To explore the potential of naturally occurring biomolecules as candidates for NAAB development.
- To discuss the developability of these candidate biomolecules for fluoro-sequencing applications.
Main Methods:
- Investigating naturally occurring biomolecules with inherent amino acid or peptide binding capabilities.
- Evaluating candidate biomolecules for their potential to be engineered into NAAB affinity reagents.
- Assessing factors influencing reagent developability, including protein size and structure.
Main Results:
- Several candidate biomolecules were identified as potential starting points for NAAB development.
- The feasibility of engineering these natural binders into selective affinity reagents was discussed.
- Key considerations for the developability of NAAB reagents were highlighted.
Conclusions:
- Leveraging naturally occurring binders offers a promising strategy for developing essential NAAB reagents.
- Successful development of NAABs is critical for advancing fluorescence-based N-terminal sequencing in proteomics.
- Further research into biomolecule engineering and developability is warranted for this next-generation sequencing technology.
Related Concept Videos
Next-generation Sequencing
97.2K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.2K
RNA-seq
11.5K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.5K
Sanger Sequencing
771.3K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
771.3K

